Erik Nauerby

Erik Nauerby is a seasoned financial professional with extensive experience in various leadership roles across multiple industries, including pharmaceuticals, medtech, and consulting. Currently serving as a Senior Financial Advisor at Hempel A/S, Erik previously held positions as an Independent Consultant at Nauerby C&C, and as Senior Financial Business Partner at LEO Pharma, where responsibilities included financial reporting and business case development for management teams. Notable prior roles include Interim CFO at Det Danske Madhus, Director of Corporate Finance at Coloplast, and CFO positions at both Millimed A/S and 7TM Pharma. Erik has a robust educational background with an MBA from Copenhagen Business School and additional certifications in coaching.